Equities

Zhongzhi Pharmaceutical Holdings Ltd

Zhongzhi Pharmaceutical Holdings Ltd

Actions
  • Price (HKD)0.95
  • Today's Change0.05 / 5.56%
  • Shares traded54.00k
  • 1 Year change-28.57%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments167396242
Total Receivables, Net336318307
Total Inventory330323268
Prepaid expenses153524
Other current assets, total261916
Total current assets8741,091857
Property, plant & equipment, net676574551
Goodwill, net1.631.631.63
Intangibles, net141518
Long term investments895651
Note receivable - long term------
Other long term assets6.756.827.51
Total assets1,7931,8751,524
LIABILITIES
Accounts payable191190121
Accrued expenses144190121
Notes payable/short-term debt273657
Current portion long-term debt/capital leases484038
Other current liabilities, total198275164
Total current liabilities609731501
Total long term debt999581
Total debt175171176
Deferred income tax202826
Minority interest4.822.972.43
Other liabilities, total121615
Total liabilities744872625
SHAREHOLDERS EQUITY
Common stock6.856.856.85
Additional paid-in capital87203203
Retained earnings (accumulated deficit)936774667
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total182022
Total equity1,0491,003899
Total liabilities & shareholders' equity1,7931,8751,524
Total common shares outstanding864864864
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.